BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22166675)

  • 21. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.
    Anderson CL; Delisle BP; Anson BD; Kilby JA; Will ML; Tester DJ; Gong Q; Zhou Z; Ackerman MJ; January CT
    Circulation; 2006 Jan; 113(3):365-73. PubMed ID: 16432067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The long QT syndrome: a clinical counterpart of hERG mutations.
    Schwartz PJ
    Novartis Found Symp; 2005; 266():186-98; discussion 198-203. PubMed ID: 16050269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted deletion of kcne2 impairs ventricular repolarization via disruption of I(K,slow1) and I(to,f).
    Roepke TK; Kontogeorgis A; Ovanez C; Xu X; Young JB; Purtell K; Goldstein PA; Christini DJ; Peters NS; Akar FG; Gutstein DE; Lerner DJ; Abbott GW
    FASEB J; 2008 Oct; 22(10):3648-60. PubMed ID: 18603586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human ether-a-go-go related gene (HERG): a chemist's perspective.
    Vaz RJ; Li Y; Rampe D
    Prog Med Chem; 2005; 43():1-18. PubMed ID: 15850821
    [No Abstract]   [Full Text] [Related]  

  • 25. [The mechanistic rote of KCNH2 gene L413P and L559H mutations in long QT syndrome].
    Li CL; Hu DY; Liu WL; Qi SY; Wang HT; Li L; Gong QM; Zhou ZF
    Zhonghua Nei Ke Za Zhi; 2007 Oct; 46(10):838-41. PubMed ID: 18218237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population.
    Liu W; Yang J; Hu D; Kang C; Li C; Zhang S; Li P; Chen Z; Qin X; Ying K; Li Y; Li Y; Li Z; Cheng X; Li L; Qi Y; Chen S; Wang Q
    Hum Mutat; 2002 Dec; 20(6):475-6. PubMed ID: 12442276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The long QT syndrome: new diagnostic and therapeutic approach in the era of molecular biology.
    Priori SG; Cantù F; Schwartz PJ
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1727-31. PubMed ID: 8893413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphisms in KCNQ1, HERG, KCNE1 and KCNE2 genes in the Chinese, Malay and Indian populations of Singapore.
    Koo SH; Ho WF; Lee EJ
    Br J Clin Pharmacol; 2006 Mar; 61(3):301-8. PubMed ID: 16487223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long QT interval in Turner syndrome--a high prevalence of LQTS gene mutations.
    Trolle C; Mortensen KH; Pedersen LN; Berglund A; Jensen HK; Andersen NH; Gravholt CH
    PLoS One; 2013; 8(7):e69614. PubMed ID: 23936059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defective assembly and trafficking of mutant HERG channels with C-terminal truncations in long QT syndrome.
    Gong Q; Keeney DR; Robinson JC; Zhou Z
    J Mol Cell Cardiol; 2004 Dec; 37(6):1225-33. PubMed ID: 15572053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. hERG1a and hERG1b potassium channel subunits directly interact and preferentially form heteromeric channels.
    McNally BA; Pendon ZD; Trudeau MC
    J Biol Chem; 2017 Dec; 292(52):21548-21557. PubMed ID: 29089383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QT interval prolongation and cardiac risk assessment for novel drugs.
    Picard S; Lacroix P
    Curr Opin Investig Drugs; 2003 Mar; 4(3):303-8. PubMed ID: 12735231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural determinants for high-affinity block of hERG potassium channels.
    Mitcheson J; Perry M; Stansfeld P; Sanguinetti MC; Witchel H; Hancox J
    Novartis Found Symp; 2005; 266():136-50; discussion 150-8. PubMed ID: 16050266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-terminal HERG (LQT2) mutations disrupt IKr channel regulation through 14-3-3epsilon.
    Choe CU; Schulze-Bahr E; Neu A; Xu J; Zhu ZI; Sauter K; Bähring R; Priori S; Guicheney P; Mönnig G; Neapolitano C; Heidemann J; Clancy CE; Pongs O; Isbrandt D
    Hum Mol Genet; 2006 Oct; 15(19):2888-902. PubMed ID: 16923798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New missense mutation (G626V) in the predicted selectivity filter of the HERG channel associated with familial long QT syndrome.
    Jahr S; Lewalter T; Hesch RD; Lüderitz B; Englisch S
    Hum Mutat; 2000 Jun; 15(6):584. PubMed ID: 10862104
    [No Abstract]   [Full Text] [Related]  

  • 36. The inherited long QT syndrome: from ion channel to bedside.
    Vincent GM; Timothy K; Fox J; Zhang L
    Cardiol Rev; 1999; 7(1):44-55. PubMed ID: 10348966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DHPLC analysis of potassium ion channel genes in congenital long QT syndrome.
    Jongbloed R; Marcelis C; Velter C; Doevendans P; Geraedts J; Smeets H
    Hum Mutat; 2002 Nov; 20(5):382-91. PubMed ID: 12402336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico screening of the impact of hERG channel kinetic abnormalities on channel block and susceptibility to acquired long QT syndrome.
    Romero L; Trenor B; Yang PC; Saiz J; Clancy CE
    J Mol Cell Cardiol; 2014 Jul; 72():126-37. PubMed ID: 24631769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel KCNQ1 and HERG missense mutations in Dutch long-QT families.
    Jongbloed RJ; Wilde AA; Geelen JL; Doevendans P; Schaap C; Van Langen I; van Tintelen JP; Cobben JM; Beaufort-Krol GC; Geraedts JP; Smeets HJ
    Hum Mutat; 1999; 13(4):301-10. PubMed ID: 10220144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG.
    Wolpert C; Schimpf R; Giustetto C; Antzelevitch C; Cordeiro J; Dumaine R; Brugada R; Hong K; Bauersfeld U; Gaita F; Borggrefe M
    J Cardiovasc Electrophysiol; 2005 Jan; 16(1):54-8. PubMed ID: 15673388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.